And not to mention, reference, MD&A Sept 30, 2021

"As at September 30, 2021 Hepalink held 35.2% (December 31, 2020 – 36.3%) of Resverlogix outstanding common shares and is considered to have significant influence over us."

And yet Don is still in charge. There has to be a very cozy relationship between Don and HL. Changes to that relationship with May 2022 looming ( the debenture) would not be a wise move. 

Koo